Nanobiotix S.A. Reports Managerial Transactions
Ticker: NBTX · Form: 6-K · Filed: Dec 12, 2024 · CIK: 1760854
Sentiment: neutral
Topics: insider-transaction, disclosure, 6-K
TL;DR
Nanobiotix filed a 6-K on Dec 12, 2024, disclosing insider transactions.
AI Summary
On December 12, 2024, Nanobiotix S.A. filed a Form 6-K to report transactions by individuals in managerial positions. The filing is a routine disclosure for foreign private issuers under the Securities Exchange Act of 1934.
Why It Matters
This filing provides transparency into the trading activities of Nanobiotix's key personnel, which can offer insights into their confidence in the company's future performance.
Risk Assessment
Risk Level: low — This is a routine disclosure of managerial transactions and does not indicate any new material risks for the company.
Key Players & Entities
- Nanobiotix S.A. (company) — Registrant
- December 12, 2024 (date) — Filing date
FAQ
What is the purpose of this Form 6-K filing by Nanobiotix S.A.?
The Form 6-K is filed to provide notification and public disclosure of transactions by persons discharging managerial responsibilities.
When was this Form 6-K filed?
This Form 6-K was filed on December 12, 2024.
What is Nanobiotix S.A.'s principal executive office address?
The principal executive offices are located at 60 rue de Wattignies, 75012 Paris, France.
Under which act and rule is this report filed?
This report is filed pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934.
What is Nanobiotix S.A.'s Central Index Key (CIK)?
Nanobiotix S.A.'s Central Index Key is 0001760854.
Filing Stats: 191 words · 1 min read · ~1 pages · Grade level 12.2 · Accepted 2024-12-12 12:04:42
Filing Documents
- a6-kformmanagerstransactio.htm (6-K) — 11KB
- exhibit991pdmrnotificati.htm (EX-99.1) — 23KB
- exhibit991pdmrnotificati001.jpg (GRAPHIC) — 93KB
- exhibit991pdmrnotificati002.jpg (GRAPHIC) — 74KB
- exhibit991pdmrnotificati003.jpg (GRAPHIC) — 113KB
- exhibit991pdmrnotificati004.jpg (GRAPHIC) — 82KB
- exhibit991pdmrnotificati005.jpg (GRAPHIC) — 65KB
- 0001760854-24-000012.txt ( ) — 622KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. NANOBIOTIX S.A. Date December 12, 2024 By Bart Van Rhijn Chief Financial Officer 3